Celera Genomics

Celera is engaged principally in integrating high throughput technologies to create therapeutic discovery and development capabilities for internal use and for its customers and collaborators. Celera businesses are its online information business and its therapeutics discovery business. The online information business is a leading provider of genomic and related biological and medical information. Pharmaceutical, biotechnology, and academic customers use this information, along with customized information technology solutions provided by Celera, to enhance their capabilities in the fields of life science research and pharmaceutical and diagnostic discovery and development. Celera recently expanded its focus to include therapeutic discovery and development. Celera intends to leverage its capabilities in genomics, proteomics, and bioinformatics, both in internal programs and through collaborations, to identify drug targets and diagnostic markers, and to discover and develop novel therapeutic candidates. Initially, Celera intends to focus its therapeutic discovery efforts in the field of oncology. In June 2001, Celera announced the signing of a definitive merger agreement with Axys, a small molecule drug discovery and development company. Celera believes that Axys’ medicinal and structural chemistry and biology capabilities will accelerate the development of its therapeutic discovery business. Celera is also participating in the commercialization of diagnostic products based on its discoveries through Celera Diagnostics, a recently announced joint venture with Applied Biosystems.

Contact Details: 45 West Gude Drive Rockville MD 20850 United States of America Tel: +1 240 453 3000 Fax: +1 240 453 4000 Email: robert.bennett@celera.com WWW: www.celera.com/

Loading...

Recent Publications by Celera Genomics:
Discovery of selective irreversible inhibitors for Bruton's tyrosine kinase. BLAST, Basic Local Alignment Search Tool is used more frequently than any...	17th July, 2008	Department of Medicinal Chemistry, Celera Genomics, 180 Kimball Way, South	ChemMedChem. 2007 Jan;2(1):58-61. DOI Direct Link
Finding homologs in amino acid sequences using network BLAST searches. BLAST, Basic Local Alignment Search Tool is used more frequently than any...	15th May, 2008	Celera Genomics, Foster City, California and Research Group for	Curr Protoc Bioinformatics. 2003 Feb;Chapter 3:Unit 3.4. DOI Direct Link
Systematic identification of pseudogenes through whole genome expression evidence profiling. The identification of pseudogenes is an integral and significant part of...	31st October, 2006	Celera Genomics, 45 West Gude Dr, Rockville, MD 20850, USA.	Nucleic Acids Res. 2006;34(16):4477-85. Epub 2006 Aug 31. DOI Direct Link
Expression and characterization of recombinant gamma-tryptase. Tryptases are trypsin-like serine proteases whose expression is restricted...	19th October, 2006	Department of Molecular Biology, Celera Genomics, 180 Kimball Way, South	Protein Expr Purif. 2006 Sep;49(1):47-54. Epub 2006 May 23. DOI Direct Link
Evaluation of antitumor properties of novel saframycin analogs in vitro and in vivo. Novel analogs of (-)-saframycin A are described. The analogs are shown to...	17th October, 2006	Celera Genomics, 180 Kimball Way, South San Francisco, CA 94080, USA.	Bioorg Med Chem Lett. 2006 Sep 15;16(18):4884-8. Epub 2006 Jul 25. DOI Direct Link
→View more Celera Genomics research publications.

BioNews Results for Celera Genomics:
Exelixis Appoints Frances K. Heller As Executive Vice President of Business Development	DiGiTAL50:  Jul 18 2008 7:10AM Matching: celera genomics
Exelixis Appoints Frances K. Heller As Executive Vice President of Business Development	Genetic Engineering News:  Jul 17 2008 9:29PM Matching: celera genomics
Exelixis Appoints Frances K. Heller As Executive Vice President of Business Development	Yahoo! Canada:  Jul 17 2008 8:33PM Matching: celera genomics
Exelixis Appoints Frances K. Heller As Executive Vice President of Business Development	Yahoo!:  Jul 17 2008 8:20PM Matching: celera genomics
Examine the Opportunities with Dyslipidemia in Cardiovascular Risk Reduction	Earthtimes.org:  Jul 17 2008 10:17AM Matching: celera genomics
Promote your company here: BioNewsCast - Press Release Distribution	→View more Celera Genomics news.

Celera Genomics (CRA) Financial information Links from Barchart
CRA Quote from from Barchart.com
CRA Chart from from Barchart.com
CRA Profile from from Barchart.com
CRA Opinion from from Barchart.com
→View more Celera Genomics finance information.

BioPortfolio Ltd provides targeted e-mail address lists for the life science sector - we can enable you to contact around 22 individuals from Celera Genomics using this service.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 531 times since April 2007, the link to the organisation's website has been followed 77 times

Recent Search Terms used to find this page: celera.com | celera.com | t | celera genomics | www.celera.com | celera genomics | t | celera genomics AND 180 | CELERA GENOMICS | celera.com | .

Search for more companies in Rockville

Search for more companies in MD

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Celera Genomics